Windlas Biotech Limited
NSE:WINDLAS.NS
Overview | Financials
Company Name | Windlas Biotech Limited |
Symbol | WINDLAS.NS |
Currency | INR |
Price | 872.4 |
Market Cap | 18,233,421,720 |
Dividend Yield | 0.74% |
52-week-range | 311.6 - 952.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Komal Gupta |
Website | https://windlasbiotech.com |
An error occurred while fetching data.
About Windlas Biotech Limited
Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD